H.R. 863 · 116th Congress
DXM Abuse Prevention Act of 2019
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
MatsuiSponsor3 cosponsors · 2 D, 1 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill addresses the sale and distribution of dextromethorphan (DXM).
What it does: CRS summary · Introduced in House · Jan 30, 2019
DXM Abuse Prevention Act of 2019
This bill addresses the sale and distribution of dextromethorphan (DXM).
Specifically, the bill requires a retailer that sells certain drugs containing DXM to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer.
The bill also establishes restrictions on (1)the sale of over-the-counter drugs containing DXM, and (2)the distribution of bulk DXM.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: DXM Abuse Prevention Act of 2019
Latest action (Jan 30, 2019): Referred to the House Committee on Energy and Commerce.
Policy area: Health · Origin: House · Introduced: Jan 30, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.